1. Home
  2. NFE vs PEPG Comparison

NFE vs PEPG Comparison

Compare NFE & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

HOLD

Current Price

$1.37

Market Cap

324.4M

Sector

Utilities

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.45

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFE
PEPG
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
317.6M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
NFE
PEPG
Price
$1.37
$5.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$7.70
$10.80
AVG Volume (30 Days)
11.5M
711.8K
Earning Date
03-02-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,768,624,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$56.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.88
52 Week High
$15.76
$7.80

Technical Indicators

Market Signals
Indicator
NFE
PEPG
Relative Strength Index (RSI) 51.11 47.69
Support Level $1.33 $5.19
Resistance Level $1.98 $6.20
Average True Range (ATR) 0.17 0.55
MACD 0.04 -0.09
Stochastic Oscillator 32.35 26.40

Price Performance

Historical Comparison
NFE
PEPG

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: